By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – A*STAR Institute of Microelectronics today announced it has signed an agreement to advance QuantuMDx's DNA sequencing nanowire biosensor to the point of commercialization.

QMDx, based in the UK, is developing a handheld all-in-one DNA sequencer, which is currently in prototype. The collaboration leverages Singapore-based A*STAR's silicon-based nanowire technology to develop technology for the simultaneous detection of large numbers of difference cells and biomaterials.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

CNBC reports that Amazon invested in the startup Grail as it sees an opportunity for its cloud computing company in genomics.

Lawrence Krauss writes at Slate that science is needed for good public policy and should not be ignored.

Researchers are working on re-making the yeast genome from scratch, according to the Associated Press.

In Cell this week: functional profiling of Plasmodium genome, a self-inactivating rabies virus, and more.